HealthSaaS.net signs reseller and integration agreement with Biosign
/THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE
Biosign and HealthSaaS.net will integrate their platforms for the recording and retrieval of in-office and remote patient vital sign measurements through the HealthSaaS.net PHR.
The first products to be integrated into the HealthSaaS.net PHR will consist of Biosign's blood pressure and hemodynamic monitors (UFIT(R) TEN-10) including automated reading, scheduling, result verification, tracking, charting and trending.
"We are continuing with our strategy of partnering with key EMR and PHR vendors to enable the availability of integrated solutions for patient management. We believe that the HealthSaaS' innovative suite of patient care services, their robust PHR, and our UFIT(R) platform collectively create an end-to-end solution for better patient care in the U.S marketplace," remarked
About Biosign Technologies Inc.
Biosign provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT(R) medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring.
About HealthSaaS.net
The HealthSaaS.net PHR is a web based Software as a Service (SaaS) application that enables patients to record multi-conditions/multi-doctors, pain locations, pain types, pain intensity, medications, naturopathic remedies, sleep patterns, treatments, therapies, exercise, activities, additional symptoms, and quality of life concerns.
The HealthSaaS.net PHR facilitates better communication between patients and their healthcare providers through account file sharing or secure Provider Portals. Patient driven report data will help providers identify both effective and ineffective treatments and medications. Healthcare providers may then make treatment and medication modifications to improve efficacy and provide patient-members with a more consistent and improved quality of life.
HealthSaaS.net also offers fee based services to support clinical trials and research studies. Fee based analytic services are available to help clinicians, researchers, pharmaceutical companies, and payors improve efficiencies.
The CNSX has neither approved nor disapproved the contents of this press release.
%SEDAR: 00014068E
For further information: Contact Information for Biosign Technologies: John T. Anders, Vice-President, Business Development, Biosign Technologies Inc., Phone: (416) 218-9800 ext. 237, Email: [email protected]; Contact Information for HealthSaaS.net: Alan Paget, Chief Technology Officer, HealthSaaS.net, Phone: (503) 882-8951, E-mail: [email protected]
Share this article